Your search history is turned on.
Date: April 25, 2024 Jurisdictions: All jurisdictions
Microsoft Word - a53955225-release Cybin to Participate at the 27th Annual Milken Institute Global Conference - Doug Drysdale, CEO, to appear on panel entitled Collaborating for Improved Mental Health, on May 8, 2024 - TORONTO--(BUSINESS WIRE)--April 25, 2024--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (Cybin or the Company), a clinical-stage biopharma...
Date: April 18, 2024 Jurisdictions: All jurisdictions
Microsoft Word - a53937843-release Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry - Publication explores structure-activity relationships (SAR) of a broad range of 2C-X analogs - - Innovative research led to the discovery of CYB210010, a potent and long-acting serotonin 5- HT2 receptor agonist with favorable pharmacoki...
Date: April 17, 2024 Jurisdictions: All jurisdictions
Microsoft Word - MNP - Prospectus Supplement Amendment No. 1 - Consent Letter April 2024 Formatted-1 Final - Conformed April 17, 2024 To the Securities Commission or similar regulatory authority in each of the provinces and territories of Canada: Dear Sir/Madam: Re: Cybin Inc. (the Company) We refer to the prospectus supplement to the short form base sh...
zeifmans.ca T: 416.256.4000 Zeifmans LLP is a member of Nexia International, a worldwide network of independent accounting and consulting firms. 201 Bridgeland Avenue | Toronto Ontario | M6A 1Y7 | Canada Conformed Version Ontario Securities Commission, as principal regulator Alberta Securities Commission B...
Microsoft Word - Cybin - Draft Prospectus Supplement - Resale of Common Shares (April 2024)(56435392.8) (003) This prospectus supplement (the Prospectus Supplement), together with the short form base shelf prospectus dated August 17, 2023, as amended pursuant to amendment no. 1 to the short form base shelf prospectus dated December 22, 2023, to which it relates, and a...
Microsoft Word - CYBN - Draft Consent of AB re Prospectus Supplement (April 2024)(56529266.2) April 17, 2024 VIA SEDAR Ontario Securities Commission, as Principal Regulator Alberta Securities Commission British Columbia Securities Commission The Manitoba Securities Commission Financial and Consumer Affairs Authority of Saskatchewan Autorit des marchs finan...
Date: April 16, 2024 Jurisdictions: All jurisdictions
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder - Newly issued patent expected to provide exclusivity until at least 2041 and includes claims to ...
Date: April 10, 2024 Jurisdictions: All jurisdictions
Microsoft Word - a53927248-release Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference TORONTO--(BUSINESS WIRE)--April 10, 2024--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (Cybin or the Company), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next- generati...
Date: April 9, 2024 Jurisdictions: All jurisdictions
Direct: April 8, 2024 VIA SEDAR Ontario Securities Commission, as principal regulator Alberta Securities Commission British Columbia Securities Commission The Manitoba Securities Commission Financial and Consumer Affairs Authority of Saskatchewan Autorit des marches financiers Office of the Superintenden...
Microsoft Word - Consent Letter April 8 2024 April 8, 2024 To the Securities Commission or similar regulatory authority in each of the provinces and territories of Canada: Dear Sir/Madam: Re: Cybin Inc. (the Company) We refer to Amendment No. 2 dated April 8, 2024 to the Short Form Base Shelf Prospectus dated August 17, 2023, as amended by Amendment No...